AcornMed Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$29.8M
- Investors
-
7
AcornMed General Information
Description
Provider of tumor genetic testing and detection services intended for precision oncology and recurrence monitoring. The company offers solid tumor profiling, hematologic malignancy diagnostics, and minimal residual disease monitoring, enabling hospitals and pharmaceutical partners to access genomic data and biomarker analysis for personalized patient care and companion diagnostic development.
Contact Information
Website
www.acornmed.comCorporate Office
- Room 601, 5th Floor, Building 3, Zone 4
- Number 22, Jinghai Fourth Road, Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Corporate Office
- Room 601, 5th Floor, Building 3, Zone 4
- Number 22, Jinghai Fourth Road, Beijing Economic-Technological Development Area
- Beijing, 100176
- China
AcornMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series B) | 13-Jul-2022 | $29.8M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 13-Apr-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 09-Apr-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-Nov-2019 | Completed | Generating Revenue | |||
| 1. Seed Round | 25-Apr-2018 | Completed | Startup |
AcornMed Patents
AcornMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025055298-A1 | Gene marker combination, kit, and detection method | Inactive | 11-Sep-2023 |
AcornMed Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elikon Venture | Growth/Expansion | Minority | ||
| Yikai Venture Capital | Growth/Expansion | Minority | ||
| Sino Ocean Investment | Corporation | Minority | ||
| Sino-Ocean Capital | Asset Manager | Minority | ||
| Indaco Capital | Venture Capital | Minority |
AcornMed FAQs
-
When was AcornMed founded?
AcornMed was founded in 2018.
-
Where is AcornMed headquartered?
AcornMed is headquartered in Beijing, China.
-
What industry is AcornMed in?
AcornMed’s primary industry is Laboratory Services (Healthcare).
-
Is AcornMed a private or public company?
AcornMed is a Private company.
-
What is the current valuation of AcornMed?
The current valuation of AcornMed is .
-
What is AcornMed’s current revenue?
The current revenue for AcornMed is .
-
How much funding has AcornMed raised over time?
AcornMed has raised $44M.
-
Who are AcornMed’s investors?
Elikon Venture, Yikai Venture Capital, Sino Ocean Investment, Sino-Ocean Capital, and Indaco Capital are 5 of 7 investors who have invested in AcornMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process